Ticker Details
Caribou Biosciences, Inc.
IPO Date:	July 23, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$210.26M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.25 | 3.80%
Avg Daily Range (30 D):	$0.06 | 2.76%
Avg Daily Range (90 D):	$0.06 | 3.48%

Institutional Daily Volume
Avg Daily Volume:	1.17M
Avg Daily Volume (30 D):	1.32M
Avg Daily Volume (90 D):	1.23M

Trade Size
Avg Trade Size (Sh.):	145
Avg Trade Size (Sh.) (30 D):	192
Avg Trade Size (Sh.) (90 D):	205

Institutional Trades
Total Institutional Trades:	515
Avg Institutional Trade:	$1.74M
Avg Institutional Trade (30 D):	$.71M
Avg Institutional Trade (90 D):	$.71M
Avg Institutional Trade Volume:	.28M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.87M
Avg Closing Trade (30 D):	$1.43M
Avg Closing Trade (90 D):	$1.43M
Avg Closing Volume:	303.05K

News

Jan 22, 2026 @ 9:56 AM Genome Editing Market Forecast to Reach $23.6 Bill... Source: Researchandmarkets.Com

Nov 3, 2025 @ 12:00 PM Caribou Biosciences Announces Positive Data from C... Source: Caribou Biosciences

Oct 2, 2025 @ 5:00 PM CRISPR Therapies Clinical Trial Pipeline Shows Pot... Source: Delveinsight

Sep 2, 2025 @ 10:00 AM Gene Editing Market to Surpass USD 15.46 Billion b... Source: Sns Insider

Jul 25, 2025 @ 11:35 PM CARIBOU ALERT: Bragar Eagel & Squire, P.C. is Inve... Source: Bragar Eagel & Squire, P.C.

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.26	$-.28	$-1.59
Diluted EPS	$-.26	$-.28	$-1.59
Revenue	$2.4M	$3.94M	$11.16M
Gross Profit
Net Income / Loss	$-25.09M	$-26.49M	$-148.13M
Operating Income / Loss	$-26.28M	$-28.45M	$-148.34M
Cost of Revenue
Net Cash Flow	$-.3M	$1.22M	$-3.93M
PE Ratio